Bausch Health Companies Inc. (BHC)
NYSE: BHC · Real-Time Price · USD
8.19
0.00 (0.00%)
Nov 20, 2024, 4:00 PM EST - Market closed
Bausch Health Companies Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for BHC stock have an average target of 7.25, with a low estimate of 3.00 and a high estimate of 11. The average target predicts a decrease of -11.48% from the current stock price of 8.19.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for BHC stock from 4 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 4 | 5 | 5 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Hold Maintains $10 → $11 | Hold | Maintains | $10 → $11 | +34.31% | Nov 1, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $10 → $8.5 | Hold | Maintains | $10 → $8.5 | +3.79% | Aug 2, 2024 |
| Piper Sandler | Piper Sandler | Hold → Sell Downgrades $9 → $3 | Hold → Sell | Downgrades | $9 → $3 | -63.37% | Aug 2, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $8 → $7 | Hold | Maintains | $8 → $7 | -14.53% | Jul 25, 2024 |
| Raymond James | Raymond James | Hold Initiates $8 | Hold | Initiates | $8 | -2.32% | Jul 10, 2024 |
Financial Forecast
Revenue This Year
9.60B
from 8.76B
Increased by 9.59%
Revenue Next Year
9.94B
from 9.60B
Increased by 3.53%
EPS This Year
3.73
from -1.62
EPS Next Year
4.40
from 3.73
Increased by 18.04%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 10.1B | 10.5B | 10.8B | ||
| Avg | 9.6B | 9.9B | 10.2B | ||
| Low | 9.3B | 9.5B | 9.7B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 14.8% | 9.0% | 9.1% | ||
| Avg | 9.6% | 3.5% | 2.6% | ||
| Low | 5.8% | -1.5% | -2.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 4.01 | 5.05 | 5.89 |
| Avg | 3.73 | 4.40 | 5.19 |
| Low | 3.49 | 3.96 | 4.58 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | 35.5% | 33.9% |
| Avg | - | 18.0% | 17.9% |
| Low | - | 6.2% | 4.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.